FDA issued a Warning Letter to Jazz Pharmaceuticals, Inc on 10/11/2011 for a previous inspection.
483 Jazz Pharmaceuticals Apr 2014

483 Jazz Pharmaceuticals Apr 2014

Sandra Saniga FDA$119.00 - Available Now

FDA investigators audited the Jazz Pharmaceuticals - Palo Alto, CA, United States facility and issued 4 inspectional observations (via FDA 483) on 04 Apr 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 04 Apr 2014
  • Location: Palo Alto, United States
  • FEI: 3005615655
Add To Cart